Psychedelic and MDMA-Related Adverse Effects—A Call for Action
This Viewpoint discusses the need to better understand potential risks associated with psychedelic and 3,4-methylenedioxymethamphetamine (MDMA) use to ensure safe and ethical practice and identifies 4 key research goals.
Authors
- Peter S. Hendricks (ORCID: https://orcid.org/0009-0004-8642-9584)
- Otto Simonsson (ORCID: https://orcid.org/0000-0003-4197-7566)
- Matthew W. Johnson
Institutions
- Sheppard and Enoch Pratt Hospital (US)
- Karolinska Institutet (SE)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.3630
- Citations
- 9
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.75
Funders
- Heffter Research Institute
- Otsuka Pharmaceutical